Healthcare Industry News: bone graft
News Release - June 30, 2011
Aesculap Implant Systems, LLC Launches Hydrolift Vertebral Body Replacement SystemCENTER VALLEY, Pa.--(Healthcare Sales & Marketing Network)-- Aesculap Implant Systems announced the availability of the new Hydrolift Vertebral Body Replacement (VBR) System. This engineering breakthrough provides surgeons with a stable, bone preserving construct for treatment of burst fractures and tumor removal of the thoracolumbar spine. The Hydrolift VBR offers the surgeon more flexibility, advanced technology, and tactile feedback during expansion due to hydrostatic distraction and the unique endplate design.
Hydrolift is the only VBR to use hydrostatic force for distraction to minimize vertebral body endplate damage and optimize tactile feedback. Applied pressure to the endplates is available via a digital read out in Bar and PSI. Additionally, Hydrolift has an expansion range of 21 to 94 mm to address the needs of one and two vertebral bodies. The advanced endplate design allows for in-situ angulation of +/- 10 degrees to precisely match the patient’s anatomic need. This feature allows the VBR to “find its own home” while eliminating the tedious step of removing the VBR to change the footplate angulation. The unique shape provides a proper balance of load transfer in the vertebral body’s region of high bone density, while optimizing area for bone growth. Spikes provide immediate stability and the unique Plasmapore® coating accentuates long term fixation.
The Hydrolift VBR is indicated for use in the thoracolumbar spine, T1 to L5, for partial or total replacement of a collapsed, damaged or unstable vertebral body due to tumor or trauma. The system is intended for use with supplemental spinal fixation systems such as the Aesculap S4®, S4 Element®, and MACS TL® systems. The Aesculap Hydrolift VBR System may be used with bone graft. The system is designed to provide anterior spinal column support even in the absence of fusion for a prolonged period. “The Hydrolift is an exciting addition to Aesculaps’ tumor/trauma product portfolio. The unique features of this device allow surgeons to provide a new level of patient care,” said Chuck DiNardo, President of Aesculap Implant Systems.
Visit www.aesculapimplantsystems.com for further information regarding Hydrolift as well as the complete tumor/trauma product portfolio.
About Aesculap Implant Systems, LLC
Aesculap Inc., a B. Braun company, founded in 1867 in Tuttlingen, Germany, is the world’s largest and one of the most respected manufacturer’s of surgical instruments and sterilization container. Aesculap is a leading privately-owned manufacturing company, passionately committed to providing high-quality, innovative products and services to all surgical disciplines, with particular focus in the fields of General, Neuro, Spine and Orthopaedics.
Aesculap Implant Systems, LLC, established by Aesculap, Inc. in 2005, focuses on delivering innovative solutions to the spine and orthopaedic markets. Aesculap Implant Systems maintains a surgeon/patient focus with the goal of improved operative procedures and patient outcomes leading to an improved quality of life. For more information about Aesculap Implant Systems or its medical products, call 800-234-9179; email us at firstname.lastname@example.org or visit www.AesculapImplantSystems.com.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun addresses the critical issues of infection prevention; medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at email@example.com or visit B. Braun at www.bbraunusa.com.
Source: Aesculap Implant Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.